🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesBlood pressure went from scary to perfect - anyone else? — my results so far

Blood pressure went from scary to perfect - anyone else? — my results so far

TomFromTexas Thu, Jan 22, 2026 at 12:14 PM 10 replies 863 viewsPage 1 of 2
TomFromTexas
Member
645
2,890
May 2024
Austin, TX
Jan 22, 2026 at 12:14 PM#1

Prescribed on cardiovascular grounds rather than for weight, and almost everything written for patients assumes the opposite.

The bit I cannot resolve on my own is how much of the SELECT benefit is plausibly independent of the weight loss, and whether that distinction changes anything practical.

I would rather have one careful answer than five confident ones.

41 19PharmD_Rodriguez, julia.endo, JessicaM_2024 and 38 others
Reply Quote Save Share Report
BethLabQueen
Senior Member
1,234
5,678
May 2024
Virginia
Online
Jan 22, 2026 at 2:03 PM#2
TomFromTexas said:
Prescribed on cardiovascular grounds rather than for weight, and almost everything written for patients assumes the opposite.

Lp(a) and cardiovascular risk: a nuance that matters. Unlike most lipid markers, Lp(a) is 90%+ genetically determined and doesn't really change with weight loss or GLP-1 therapy.

My Lp(a) has remained at 41 nmol/L across all time points. If yours is elevated (>50 nmol/L), you need additional risk mitigation strategies regardless of your GLP-1 response. Don't assume your medication is covering all cardiovascular risk factors.

42 20Dr.PulmRoch, maya_sedona, stefan_berlin and 39 others
Reply Quote Save Share Report
mike_nyc
VIP Member
5,678
21,345
Nov 2023
New York
Online
Jan 22, 2026 at 3:52 PM#3
BethLabQueen said:
Lp(a) and cardiovascular risk: a nuance that matters.

Cardiac biomarkers and cardiovascular risk: my cardiologist ordered advanced cardiac labs given my family history. Results were encouraging:

  • NT-proBNP: 67 pg/mL (normal, cardiac function preserved)
  • Lp(a): 27 nmol/L (genetic, unchanged — expected)
  • ApoB: dropped from 157 to 92 mg/dL (excellent response)
  • Coronary calcium score: 0 (unchanged from baseline — reassuring)

The ApoB reduction is particularly meaningful — it's considered the best single predictor of cardiovascular risk. GLP-1 therapy seems to improve this consistently.

43 21Dr.EM_Chicago, pete_RVA, CarlaRPh_TPA and 40 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
andrew_nyc
Member
534
2,345
Apr 2024
New York, NY
Jan 22, 2026 at 5:41 PM#4
TomFromTexas said:
Prescribed on cardiovascular grounds rather than for weight, and almost everything written for patients assumes the opposite.

This matches mine closely enough to be worth saying so out loud. Nothing to add that would improve it.

44 22julia.endo, JessicaM_2024, TomFromTexas and 41 others
Reply Quote Save Share Report
VanRx_Mike
Member
678
2,890
May 2024
Vancouver, CA
Jan 23, 2026 at 4:21 AM#5

From the other side of the consultation, briefly.

Dizziness and cardiovascular risk: I was lightheaded for the first 2 weeks. Root cause was a combination of reduced caloric intake and mild dehydration.

Fix: minimum 80-100oz water daily, don't skip meals even if you're not hungry (eat small protein-rich snacks), and stand up slowly from sitting/lying positions. Also check your blood pressure — GLP-1-induced weight loss can make BP meds too strong, requiring dose reduction.

45 23mike_mod, SarahChen_PharmD, sarah.morrison and 42 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register